Leonel Hidalgo

Dr. Leonel Hidalgo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
DPDominga Peirano
Dominga Peirano
FDFrancisca Donoso
Francisca Donoso
SVSebastian Vargas
Sebastian Vargas
LHLeonel Hidalgo
Leonel Hidalgo
RARosario Agüero
Rosario Agüero
Cristian Navarrete-DechentCristian Navarrete-Dechent
Cristian Navarrete-Dechent
The incidence of melanoma has been dramatically increasing over the last decades. Melanoma is considered to have a high metastatic potential and it can progress due to hematogenous metastasis or via lymphatic vessels. Different patterns of recurrence have been described, namely, local, satellite, and in transit metastasis (LCIT), lymphatic, and systemic metastasis. With a more advanced melanoma stage at diagnosis, there is a higher risk for systemic metastasis in comparison to LCIT; in contrast, early-stage melanoma tends to recur more frequently as LCIT and less commonly as systematic metastasis. The aim of this review was to summarize the patterns of recurrence of cutaneous melanoma, giving the clinician a practical summary for diagnosis, prognosis, and surveillance. There is a knowledge gap of the common patterns of recurrence that needs to be addressed to better identify patients at high risk of disease recurrence and personalize surveillance strategies as well as patient counseling.

27 September 2022 in Dermatologic Therapy
Verified
Journal Article
Closed access
LHLeonel Hidalgo
Leonel Hidalgo
CSCristóbal Saldías‐Fuentes
Cristóbal Saldías‐Fuentes
KCKarina Carrasco
Karina Carrasco
AHAllan C. Halpern
Allan C. Halpern
JMJun J. Mao
Jun J. Mao
Cristian Navarrete-DechentCristian Navarrete-Dechent
Cristian Navarrete-Dechent
Complementary and alternative medicine or therapies (CAM) are frequently used by skin cancers patients. Patient's self-administration of CAM in melanoma can reach up to 40%-50%. CAMs such as botanical agents, phytochemicals, herbal formulas ("black salve") and cannabinoids, among others, have been described in skin cancer patients. The objective of this review article was to acknowledge the different CAM for skin cancers through the current evidence, focusing on biologically active CAM rather than mind-body approaches. We searched MEDLINE database for articles published through July 2022, regardless of study design. Of all CAMs, phytochemicals have the best in vitro evidence-supporting efficacy against skin cancer including melanoma; however, to date, none have proved efficacy on human patients. Of the phytochemicals, Curcumin is the most widely studied. Several findings support Curcumin efficacy in vitro through various molecular pathways, although most studies are in the preliminary phase. In addition, the use of alternative therapies is not exempt of risks physicians should be aware of their adverse effects, interactions with standard treatments, and possible complications arising from CAM usage. There is emerging evidence for CAM use in skin cancer, but no human clinical trials support the effectiveness of any CAM in the treatment of skin cancer to date. Nevertheless, patients worldwide frequently use CAM, and physicians should educate themselves on currently available CAMs.

10 October 2024 in JEADV Clinical Practice
Verified
Journal Article
Open access
LHLeonel Hidalgo
Leonel Hidalgo
MSMaría Paz Salinas
María Paz Salinas
JSJaviera Sepúlveda
Javiera Sepúlveda
KCKarina Carrasco
Karina Carrasco
PRPamela Romero
Pamela Romero
Cristian Navarrete-DechentCristian Navarrete-Dechent
Cristian Navarrete-Dechent

25 January 2022 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
LHLeonel Hidalgo
Leonel Hidalgo
FDFrancisca Donoso
Francisca Donoso
MGMariana Guzmán
Mariana Guzmán
RMRocío Millán
Rocío Millán
MCMaximiliano Curi
Maximiliano Curi
Cristian Navarrete-DechentCristian Navarrete-Dechent
Cristian Navarrete-Dechent
Click on the article title to read more.

20 November 2023 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
DPDominga Peirano
Dominga Peirano
SVSebastián Vargas
Sebastián Vargas
LHLeonel Hidalgo
Leonel Hidalgo
FDFrancisca Donoso
Francisca Donoso
EAEugenia Abusleme
Eugenia Abusleme
Cristian Navarrete-DechentCristian Navarrete-Dechent
Cristian Navarrete-Dechent
Background: Skin cancer is the most frequent cancer worldwide and the most frequent periocular tumor. Keratinocyte Carcinomas (KC) located in periorificial areas, such as periocular tumors, are considered high-risk tumors. Mohs Micrographic Surgery (MMS) is considered the first line for the treatment of high-risk KC, providing a lower recurrence rate than conventional wide excision. Objective: To describe the clinical-pathological features of periocular KC treated with MMS in a tertiary university center in Chile. Methods: A single-center, retrospective study of patients with KC located on the periocular area, that underwent MMS between 2017‒2022. MMS details were recorded. Results: One hundred thirteen patients with periocular carcinomas were included. The mean age was 59 ± 13 years; 52% were women. The most frequent location was the medial canthus (53%), followed by the lower eyelid (30.1%). The most frequent BCC histology was the nodular variant (59.3%). Regarding MMS, the average number of stages was 1.5 ± 0.7, and 54% of the cases required only 1 stage to achieve clear margins. To date, no recurrence has been reported. Tumors larger than 8.5 mm in largest diameter or 43.5 mm 2 were more likely to require complex reconstruction. Study limitations: Retrospective design and a relatively low number of patients in the SCC group. Possible selection bias, as larger or more complex cases, may have been referred to oculoplastic surgeons directly. Conclusion: The present study confirms the role of MMS for the treatment of periocular KCs. Periocular KCs larger than 8.5 mm might require complex reconstruction. These results can be used to counsel patients during pre-surgical visits.

26 September 2023 in Experimental Dermatology
Verified
Journal Article
Closed access
LHLeonel Hidalgo
Leonel Hidalgo
KHKatharine L. Hanlon
Katharine L. Hanlon
LCLilia Correa‐Selm
Lilia Correa‐Selm
MVMiguel A. Villaseca
Miguel A. Villaseca
KCKarina Carrasco
Karina Carrasco
Cristian Navarrete-DechentCristian Navarrete-Dechent
Cristian Navarrete-Dechent